Cargando...
Nanobodies: new avenue to treat kidney disease
Current therapeutic options for renal diseases are limited, and the search for disease-specific treatments is ongoing. Nanobodies, single-domain antibodies with many advantages over conventional antibodies, provide flexible, easy-to-format biologicals with many possible applications. Here, we discus...
Gardado en:
| Publicado en: | Cell Tissue Res |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Springer Berlin Heidelberg
2021
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8205650/ https://ncbi.nlm.nih.gov/pubmed/34131806 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00441-021-03479-8 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|